Feed Companies Agents Subscribe

Loading...

Companies
Zim Laboratories Limited
Important

Important03-12-2025 · 01:49 pm IST·Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

ZIM Labs received CDSCO approval for its innovative Naproxen + Esomeprazole FDC capsules, boosting its pain management & gastro-protective portfolio.

Zim Laboratories LimitedZIMLAB · Filed with the exchange

A commercial supply agreement is signed, targeting India launch in FY26-27. This reinforces ZIM's strategy in differentiated generics.

Read the original filing(PDF)

No comments yet. Be the first.

More from Zim Laboratories Limited

All announcements

Investor Meet08-08-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Others07-08-2026
Copy of Newspaper Publication
Updates06-08-2026
General Updates
Board Meeting06-08-2026
Outcome of Board Meeting
Investor Meet04-08-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Others30-07-2026
Copy of Newspaper Publication

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.